BiotechTube
Home/Atamyo Therapeutics/Pr. Isabelle Richard
PI

Pr. Isabelle Richard

Scientific Founder / Laboratory Head at Genethon

Atamyo Therapeutics

Therapeutic Areas

Neuromuscular DiseasesRare Genetic Disorders

Atamyo Therapeutics Pipeline

DrugIndicationPhase
ATA-100Limb-Girdle Muscular Dystrophy Type R9 (FKRP-related)Phase 1b/2b
ATA-200Limb-Girdle Muscular Dystrophy Type R5 (γ-sarcoglycan-related)Phase 1/2